What to know about GLP-1s linked to sudden blindness @azfamily
What to know about GLP-1s linked to sudden blindness  @azfamily
Uploaded November 2026 | Updated November 2026, 3 days ago
The U.S. Food and Drug Administration now requires all weight loss drugs to carry a warning label about a potential increased risk of sudden blindness, according to new guidance from the agency.

Experts say the condition is known as non-arteritic anterior ischemic optic neuropathy, or as NAION, and it comes out of nowhere.|

Micaela Marshall reports: azfamily.com/2026/11/10/fda-requires-blindness-warning-label-glp-1-drugs

For more Local News from KPHO: azfamily.com
For more YouTube Content: youtube.com/channel/UCIrgpHvUm1FMtv-C1xwkJtw
What to know about GLP-1s linked to sudden blindnessHorse owner arrested after deadly Camp Verde flooding #arizonaWhen will Mattel City open? Glendale project unveils bigger plansCredit card debt reaches new staggering record highFamilies stage ‘sickout’ in Buckeye school district over alleged issuesMobile clinic brings care to Navajo moms #arizonaWill it rain in Phoenix this weekend? Here’s what to expectPets on Parade (full episode) November 14, 2026Full interview: AG Kris Mayes lays out whats next for ArizonaWitness describe deadly Washington D.C. shootingAngies in Chandler among this weeks violationsTwo people shot inside Desert Sky Mall in west Phoenix
Arizona’s Family (3TV / CBS 5) |

What to know about GLP-1s linked to sudden blindness

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER